| Invention Title |
Inventor Name(s) |
|
A Novel Peroxiredoxin Defense System from Mycobacterium tuberculosis |
Carl Nathan,
Ruslana Byrk,
Christopher Lima
|
|
CL-01 Cell: A Human Monoclonal IgM+IgD+ B Cell Line |
Paolo Casali,
Andrea Cerutti
|
|
Fungicidal Toxins from Biocontrol Bacteria |
Jon Clardy,
Jo Handelsman,
Haiyin He,
Laura Silo-Suh
|
|
Genes Encoding Subunits of DNA Polymerase III Holoenzyme |
Michael O'Donnell
|
|
Genetic Vaccines Directed Against Bacterial Exotoxins |
Ronald Crystal,
Neil Hackett,
Yadi Tan
|
|
Genetic Vaccines Directed Against Yersinia pestis |
Ronald Crystal,
Julie Boyer
|
|
Methods for Treating Tuberculosis by Inhibiting a Membrane Protein and Disrupting the Acid Resistance of Myobacterium Tuberculosis |
Sabine Ehrt,
Carl Nathan,
Omar Vandal
|
|
Mycobacterium Tuberculosis Proteasome Inhibiting Compounds |
Carl Nathan,
Gang Lin
|
|
Novel DNA Vaccine Targeting the Receptor Binding Domain of Clostridium Difficile Toxin A |
David Gardiner,
Yaoxing Huang
|
|
Novel Target and Rhodanine Derivatives for prevention and treatment of Tuberculosis and Other Infectious Diseases |
Carl Nathan,
Ruslana Bryk,
Mark Gurney,
Krzysztof Pupek,
Raghu Samy,
Jasbir Singh
|
|
Novel Targets for Anti-Infectives against Bacteria |
Jochen Buck,
Leo Brizuela,
Lonny Levin,
Michael Pinnisi
|
|
Streptococcus bovis HC5, a Bacterium that Inhibts Deterimental Bacteria |
James Russell (Deceased),
Hilario Manovani
|
|
Treating Latent & Active Tuberculosis without Causing Drug Resistance |
Carl Nathan,
Luiz Pedro de Carvalho
|
Showing
complete results (13)